Mendel Goldfinger

1.8k total citations · 1 hit paper
53 papers, 738 citations indexed

About

Mendel Goldfinger is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Mendel Goldfinger has authored 53 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 15 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Mendel Goldfinger's work include Acute Myeloid Leukemia Research (17 papers), Multiple Myeloma Research and Treatments (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Mendel Goldfinger is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Multiple Myeloma Research and Treatments (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Mendel Goldfinger collaborates with scholars based in United States, Australia and India. Mendel Goldfinger's co-authors include Amit Verma, Kith Pradhan, Benjamin A. Gartrell, Ana Acuña-Villaorduña, Stan Reissman, Daniel J. Cole, Richard V. Smith, Rafi Kabarriti, Vikas Mehta and Román Pérez-Soler and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Mendel Goldfinger

38 papers receiving 724 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

2020 521 citations Vikas Mehta, Sanjay Goel et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mendel Goldfinger United States	8	557	312	90	79	76	53	738
Wenjuan He China	7	267 0.5×	306 1.0×	34 0.4×	30 0.4×	52 0.7×	14	513
Urshila Durani United States	15	220 0.4×	59 0.2×	50 0.6×	66 0.8×	152 2.0×	63	765
Bradley D. Hunter United States	11	277 0.5×	179 0.6×	46 0.5×	21 0.3×	90 1.2×	38	727
Benjamin A. Gartrell United States	17	823 1.5×	322 1.0×	94 1.0×	33 0.4×	586 7.7×	74	1.4k
Jessica E. Hawley United States	8	358 0.6×	78 0.3×	28 0.3×	16 0.2×	128 1.7×	43	894
Melissa Lumish United States	12	374 0.7×	97 0.3×	31 0.3×	12 0.2×	129 1.7×	38	493
Amy Liu United States	13	234 0.4×	63 0.2×	50 0.6×	18 0.2×	27 0.4×	43	675
Ahmad Alhuraiji Kuwait	8	393 0.7×	129 0.4×	70 0.8×	5 0.1×	54 0.7×	38	638
Adela Mattiazzi United States	21	153 0.3×	146 0.5×	26 0.3×	21 0.3×	151 2.0×	56	1.8k
Feng Jung Sherida H. Woei-A-Jin Belgium	13	247 0.4×	48 0.2×	32 0.4×	17 0.2×	49 0.6×	38	560

Countries citing papers authored by Mendel Goldfinger

Since Specialization

Citations

This map shows the geographic impact of Mendel Goldfinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mendel Goldfinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mendel Goldfinger more than expected).

Fields of papers citing papers by Mendel Goldfinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mendel Goldfinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mendel Goldfinger. The network helps show where Mendel Goldfinger may publish in the future.

Co-authorship network of co-authors of Mendel Goldfinger

This figure shows the co-authorship network connecting the top 25 collaborators of Mendel Goldfinger. A scholar is included among the top collaborators of Mendel Goldfinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mendel Goldfinger. Mendel Goldfinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hammami, M Bakri, Mendel Goldfinger, Nishi Shah, et al.. (2024). Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort. Transplantation and Cellular Therapy. 30(5). 544.e1–544.e8. 3 indexed citations

Yan, John, M Bakri Hammami, Nishi Shah, et al.. (2024). Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database. Annals of Hematology. 103(9). 3543–3551.

Yan, John, et al.. (2024). Testosterone therapy as a novel approach to the management of cytopenias in myelodysplastic neoplasms: a review of literature and case report. Journal of Cancer Research and Clinical Oncology. 150(8).

Li, Xing, Xiaohua Qi, Qing Wang, et al.. (2024). Immunophenotypic, genetic, and clinical characterization of adult T-cell leukemia/lymphoma: A single tertiary care center experience in the United States. American Journal of Clinical Pathology. 163(2). 205–214.

Sisto, Alex, David Levitz, Ioannis Mantzaris, et al.. (2023). Transportation Cost Is a Significant Barrier to Quality Care for Hematologic Malignancy Patients in a Minority-Rich, Socioeconomically Disadvantaged Population. Blood. 142(Supplement 1). 2350–2350. 1 indexed citations

Jain, Salvia, Constantine S. Tam, Francesca Montanari, et al.. (2023). Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma. Blood Advances. 7(14). 3760–3763. 9 indexed citations

Levitz, David, Yogen Saunthararajah, Lauren Shapiro, et al.. (2023). A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML. Clinical Cancer Research. 29(15). 2774–2780. 10 indexed citations

Sisto, Alex, David Levitz, Ioannis Mantzaris, et al.. (2023). A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx. Blood. 142(Supplement 1). 7397–7397.

Shapiro, Lauren M., Ioannis Mantzaris, Aditi Shastri, et al.. (2022). AML-351 Low-Dose Weekly Decitabine and Venetoclax in Myeloid Malignancies. Clinical Lymphoma Myeloma & Leukemia. 22. S241–S241.

10.

Shapiro, Lauren, Ioannis Mantzaris, Aditi Shastri, et al.. (2022). Low-dose weekly decitabine and venetoclax in TP53-mutated myeloid malignancies.. Journal of Clinical Oncology. 40(16_suppl). e19005–e19005. 1 indexed citations

11.

Goldfinger, Mendel & Dennis Cooper. (2021). Refractory DLBCL: Challenges and Treatment. Clinical Lymphoma Myeloma & Leukemia. 22(3). 140–148. 15 indexed citations

12.

Kalac, Matko, Constantine S. Tam, Mendel Goldfinger, et al.. (2021). A Real World Experience of Combined Treatment with Romidepsin and Azacitidine in Patients with Peripheral T-Cell Lymphoma. Blood. 138(Supplement 1). 4550–4550. 1 indexed citations

13.

Thakkar, Astha, Kira Gritsman, Mendel Goldfinger, et al.. (2021). Cardiovascular Side Effects of Chimeric Antigen Receptor (CAR) T-Cell Products: A Single Center Experience in a Minority Rich, Ethnically Diverse Real-World Cohort. Blood. 138(Supplement 1). 3840–3840.

14.

Mehta, Vikas, Sanjay Goel, Rafi Kabarriti, et al.. (2020). Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System. Cancer Discovery. 10(7). 935–941. 521 indexed citations breakdown →

15.

Goldfinger, Mendel, Mina L. Xu, Joseph R. Bertino, & Dennis Cooper. (2019). Checking in on Lenalidomide in Diffuse Large B Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 19(6). e307–e311. 5 indexed citations

16.

Goldfinger, Mendel, et al.. (2019). An Institutional Retrospective Study on Recognizing the Delay in Multiple Myeloma Diagnosis. Blood. 134(Supplement_1). 3430–3430. 2 indexed citations

17.

Goldfinger, Mendel, et al.. (2019). Management of Hodgkin Lymphoma in a Sickle Cell Patient: A Case Report. Case Reports in Oncology. 12(1). 224–227.

18.

Patel, Eshan U., et al.. (2018). A Case of Vanishing Metastatic Mass: Right Atrial Mass in the Setting of Primary Epithelioid Hemangioendothelioma of the Spine. Case Reports in Oncology. 11(2). 534–540. 4 indexed citations

19.

Goldfinger, Mendel, et al.. (2018). Paraneoplastic Seronegative Pauci-Immune Glomerulonephritis Associated with Lung Adenocarcinoma Responds to Rituximab: A Case Report. Case Reports in Oncology. 11(2). 372–377. 3 indexed citations

20.

Nevadunsky, Nicole, Anne Van Arsdale, Howard D. Strickler, et al.. (2014). Obesity and Age at Diagnosis of Endometrial Cancer. Obstetrics and Gynecology. 124(2). 300–306. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact